Alimera's Iluvien proving effective in phase 3 clinical trials. Iluvien will release fluocinolone acetonide for the treatment of diabetic macular edema. Iluvien is an injectable extended release delivery system.
Retinal specialists have been using intravitreal injections to treat retinal disease. Sustained release systems are gaining in popularity. Soon, more than retinal disease will be treated with these devices.